InnoCare Pharma Limited
INCPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $40,232 | $39,475 | $33,268 | $36,535 |
| - Cash | $6,223 | $8,225 | $8,698 | $5,929 |
| + Debt | $1,272 | $1,349 | $1,253 | $1,268 |
| Enterprise Value | $35,281 | $32,599 | $25,823 | $31,875 |
| Revenue | $1,009 | $739 | $625 | $1,043 |
| % Growth | 36.7% | 18.1% | -40% | – |
| Gross Profit | $871 | $610 | $482 | $977 |
| % Margin | 86.3% | 82.6% | 77.1% | 93.7% |
| EBITDA | -$313 | -$517 | -$808 | -$167 |
| % Margin | -31% | -69.9% | -129.2% | -16% |
| Net Income | -$441 | -$631 | -$887 | -$65 |
| % Margin | -43.7% | -85.5% | -141.8% | -6.2% |
| EPS Diluted | -0.26 | -0.37 | -0.6 | -0.037 |
| % Growth | 29.7% | 38.3% | -1,539.3% | – |
| Operating Cash Flow | -$366 | -$671 | -$566 | $167 |
| Capital Expenditures | -$78 | -$255 | -$370 | -$167 |
| Free Cash Flow | -$444 | -$926 | -$936 | -$0 |